FI56487B - Foerfarande foer framstaellning av en laett fluidiserbar inhalerbar farmaceutisk komposition - Google Patents

Foerfarande foer framstaellning av en laett fluidiserbar inhalerbar farmaceutisk komposition

Info

Publication number
FI56487B
FI56487B FI191/73A FI19173A FI56487B FI 56487 B FI56487 B FI 56487B FI 191/73 A FI191/73 A FI 191/73A FI 19173 A FI19173 A FI 19173A FI 56487 B FI56487 B FI 56487B
Authority
FI
Finland
Prior art keywords
inhalerbar
fluidiserbar
laett
framstaellning
requirements
Prior art date
Application number
FI191/73A
Other languages
English (en)
Other versions
FI56487C (fi
Inventor
Donald Ross Macarthur
David Ernest Smith
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36763080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI56487(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of FI56487B publication Critical patent/FI56487B/fi
Application granted granted Critical
Publication of FI56487C publication Critical patent/FI56487C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI191/73A 1971-08-10 1973-01-24 Foerfarande foer framstaellning av en laett fluidiserbar inhalerbar farmaceutisk komposition FI56487C (fi)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB3745671A GB1410588A (en) 1971-08-10 1971-08-10 Composition
GB3745671 1971-08-10
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
DK392872 1972-08-09
ZA730284A ZA73284B (en) 1971-08-10 1973-01-15 Pharmaceutical powder composition containing sodium cromoglycate
ZA7300284 1973-01-15
AU5119173 1973-01-17
AU51191/73A AU5119173A (en) 1971-08-10 1973-01-17 Composition
ES410910A ES410910A1 (es) 1971-08-10 1973-01-24 Un procedimiento para la preparacion de una composicion farmaceutica en polvo para inhalacion.
ES410910 1973-01-24

Publications (2)

Publication Number Publication Date
FI56487B true FI56487B (fi) 1979-10-31
FI56487C FI56487C (fi) 1980-02-11

Family

ID=36763080

Family Applications (1)

Application Number Title Priority Date Filing Date
FI191/73A FI56487C (fi) 1971-08-10 1973-01-24 Foerfarande foer framstaellning av en laett fluidiserbar inhalerbar farmaceutisk komposition

Country Status (19)

Country Link
US (1) US4009280A (fi)
JP (1) JPS5652001B2 (fi)
AT (1) AT333974B (fi)
AU (1) AU5119173A (fi)
CA (1) CA992461A (fi)
DE (1) DE2239091A1 (fi)
DK (2) DK131891C (fi)
ES (1) ES410910A1 (fi)
FI (1) FI56487C (fi)
FR (1) FR2150759B1 (fi)
GB (1) GB1410588A (fi)
IE (1) IE37102B1 (fi)
IL (1) IL39990A (fi)
LU (1) LU66875A1 (fi)
NL (1) NL7210780A (fi)
NO (1) NO140747C (fi)
SE (1) SE411842B (fi)
ZA (1) ZA73284B (fi)
ZM (1) ZM11971A1 (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5042819A (fi) * 1973-08-20 1975-04-18
JPS5042827A (fi) * 1973-08-20 1975-04-18
JPS5042826A (fi) * 1973-08-20 1975-04-18
JPS6019043B2 (ja) * 1975-12-11 1985-05-14 ソニー株式会社 磁気再生装置
JPS5313111U (fi) * 1976-07-16 1978-02-03
US4238502A (en) * 1978-08-03 1980-12-09 Fisons Limited Method of treating psychiatric conditions
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
ATE239447T1 (de) † 1997-09-29 2003-05-15 Inhale Therapeutic Syst In verneblern verwendbare, stabilisierte zubereitungen
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
CA2382821A1 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
EP1280520B2 (en) 2000-05-10 2018-03-21 Novartis AG Phospholipid-based powders for drug delivery
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
AU2001280934A1 (en) * 2000-07-28 2002-02-13 Alliance Pharmaceutical Corp. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
JP2005504715A (ja) 2000-12-29 2005-02-17 アドバンスト インハレーション リサーチ，インコーポレイテッド 持続放出特性を有する吸入用粒子
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
WO2002062317A2 (en) * 2001-02-06 2002-08-15 Innovata Biomed Limited Bimodal dry powder formulation for inhalation
US20030129250A1 (en) * 2001-11-20 2003-07-10 Advanced Inhalation Research Inc. Particulate compositions for improving solubility of poorly soluble agents
ES2415654T3 (es) * 2001-11-20 2013-07-26 Civitas Therapeutics, Inc. Composiciones particuladas mejoradas para suministro pulmonar
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
CN102119238B (zh) * 2008-07-24 2014-05-28 乔治洛德方法研究和开发液化空气有限公司 沉积含过渡金属的膜的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121096A (en) * 1961-12-27 1964-02-11 Roussel Uclaf New process of preparation of 3-methyl chromone
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190194A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-Phenoxy Compounds and Chromanone and Chromone Derivatives
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1223690A (en) * 1967-10-17 1971-03-03 Fisons Pharmaceuticals Ltd Substituted chromon-2-carboxylic acids
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ZM11971A1 (en) 1973-02-21
CA992461A (en) 1976-07-06
ES410910A1 (es) 1976-07-16
DK535774A (fi) 1975-06-02
GB1410588A (en) 1975-10-22
DK146974B (da) 1984-03-05
LU66875A1 (fi) 1973-03-23
NL7210780A (fi) 1973-02-13
FI56487C (fi) 1980-02-11
AU5119173A (en) 1974-07-18
AT333974B (de) 1976-12-27
IL39990A (en) 1977-02-28
IL39990A0 (en) 1972-09-28
JPS5652001B2 (fi) 1981-12-09
DK131891C (da) 1976-02-23
JPS4826764A (fi) 1973-04-09
ZA73284B (en) 1973-11-28
SE411842B (sv) 1980-02-11
DK146974C (da) 1984-08-13
DE2239091A1 (de) 1973-02-22
FR2150759A1 (fi) 1973-04-13
IE37102B1 (en) 1977-05-11
FR2150759B1 (fi) 1975-10-31
NO140747B (no) 1979-07-30
NO140747C (no) 1979-11-07
ATA39073A (de) 1976-04-15
US4009280A (en) 1977-02-22
DK131891B (da) 1975-09-22

Similar Documents

Publication Publication Date Title
FI56487B (fi) Foerfarande foer framstaellning av en laett fluidiserbar inhalerbar farmaceutisk komposition
AT320992B (de) Stabilisierte Zusammensetzung
BE789950A (fr) Composition photopolymerisable
FI54052B (fi) Hygienisk-kosmetisk komposition foer behandling av hud
SE382958B (sv) Lasring for behallarlock
RO77018A (ro) Compozitie fitotoxica
BE768269A (fr) Composition pharmaceutique
BG26673A3 (bg) Фотоколимеризуем състав
BE793266A (fr) Composition photopolymerisable
IE35991L (en) Camphor-containing pharmaceutical composition
BE782981A (fr) Compositions pharmaceutiques
IT966335B (it) Composizione disinfestante
IT1050203B (it) Composizione antitraspirante
BE775640A (fr) Composition pharmaceutique
SE373315B (sv) Slitlenk for deckkedjor
BE782444A (fr) Compositions pharmaceutiques
FI55882B (fi) Anordning foer spetsdragning av banformigt material
SE396102B (sv) Berband for blixtlas
BE776768A (fr) Composition pharmaceutique
BE775619A (fr) Compositions anesthesiques
SE411123B (sv) Komposition for enterala overdrag
FR2100950A1 (fr) Composition pharmaceutique
SE391327B (sv) Leggsten for planglasugn
SE396101B (sv) Berband for blixtlas
ZA721363B (en) Pharmaceutical composition